About me
Jim Wilkinson, Ph.D. is currently US Medical Lead, Medical Affairs & Evidence Generation with argenx.
Jim is an experienced and innovative leader in global and US Medical Affairs, with over 22 years in the biopharma industry. He has worked in several therapeutic areas while also launching multiple products throughout the course of his career. His in-depth understanding of synergies and differences between global, regional, and local teams allows for successful cross-functional and cross-geographical partnerships. Before joining argenx, Jim was at Amgen where he held a breadth of roles with increasing scope and responsibilities within Medical Affairs. Roles included leading Global and US Medical Information, Global Publications, Global and US Medical Communications, Global Field-Based Medical, and US Medical Science Liaison (MSL) teams. He was also the medical lead for several company integrations, including Amgen’s acquisition of Horizon Therapeutics. In addition, Jim served on the Board of Directors for Amgen’s non-profit Safety Net Program and on the U.S. Patient Assistance Program governance committee. Jim received his B.S. in Biochemistry from the University of Wisconsin-Madison and obtained his Ph.D. in Biochemistry, Molecular Biology and Biophysics from the University of Minnesota-Minneapolis. Prior to joining industry, Jim completed a post-doctoral fellowship in pediatric hematology-oncology at the University of Minnesota-Minneapolis Cancer Center.